A recent study by the Breast Cancer Consortium found an ATM mutation in 294 of 60,466 women with breast cancer (0.49%) and 150 or 53,461 controls (0.28%) (OR 2.10, 95% CI 1.71–2.57). This evidence concerns the gene ATM and breast carcinoma.